Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Wan‐Teck Lim's publication output changed over time?
ScholarIQpublication output · 2006–2023
Output grew100% over the shown period — from 1 works in 2006 to 2 in 2023.
1
1
2
1
1
1
1
1
2
200620122013201520172018202020212023
What are the most-cited papers on Wan‐Teck Lim?
ScholarIQmost cited works
Isolation and retrieval of circulating tumor cells using centrifugal forces
Han Wei Hou, Majid Ebrahimi Warkiani, Bee Luan Khoo, Zirui Li, Ross A. Soo, Daniel Shao-Weng Tan, Wan‐Teck Lim, Jongyoon Han, Ali Asgar S. Bhagat, Chwee Teck Lim
Scientific Reports. 2013731 CitationsOPEN ACCESS
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
King Pan Ng, Axel M. Hillmer, Charles Chuah, Wen Chun Juan, Tun Kiat Ko, Audrey S.M. Teo, Pramila Ariyaratne, Naoto Takahashi, Kenichi Sawada, Yao Fei, Sheila Soh, Wah Heng Lee, John W J Huang, John Carson Allen, Xing Yi Woo, Niranjan Nagarajan, Vikrant Kumar, Anbupalam Thalamuthu, Wan Ting Poh, Ai Leen Ang, Hae Tha Mya, Gee Fung How, Li Yi Yang, Liang Piu Koh, Balram Chowbay, Chia-Tien Chang, Veera Sekaran Nadarajan, Wee Joo Chng, Hein Than, Lay Cheng Lim, Yeow Tee Goh, Shenli Zhang, Dianne Poh, Patrick Tan, Ju‐Ee Seet, Mei‐Kim Ang, Noan‐Minh Chau, Quan‐Sing Ng, Daniel S.W. Tan, Manabu Soda, Kazutoshi Isobe, Markus M. Nöthen, Tien Yin Wong, Atif Shahab, Xiaoan Ruan, Valère Cacheux-Rataboul, Wing‐Kin Sung, Eng Huat Tan, Yasushi Yatabe, Hiroyuki Mano, Ross A. Soo, Tan Min Chin, Wan‐Teck Lim, Yijun Ruan, S. Tiong Ong
Nature Medicine. 2012556 Citations
Genomic landscape of lung adenocarcinoma in East Asians
Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, Lidyana Bte Amer, Faranak Ghazi Sherbaf, Chu Quan Tan, Jacob J.S. Alvarez, Bingxin Lu, Jia Qi Lim, Angela Takano, Rahul Nahar, Yin Yeng Lee, Cheryl Zi Jin Phua, Khi Pin Chua, Lisda Suteja, Pauline Jieqi Chen, Mei Mei Chang, Tina Puay Theng Koh, Boon‐Hean Ong, Devanand Anantham, Anne Ann Ling Hsu, Apoorva Gogna, Chow Wei Too, Zaw Win Aung, Yi Fei Lee, Lanying Wang, Tony Kiat Hon Lim, Andreas Wilm, Poh Sum D. Choi, Poh Yong Ng, Chee‐Keong Toh, Wan‐Teck Lim, Siming Ma, Bing Lim, Jin Liu, Wai Leong Tam, Anders J. Skanderup, Joe Yeong, Eng-Huat Tan, Caretha L. Creasy, Daniel S.W. Tan, Axel M. Hillmer, Weiwei Zhai
S137905309. 2020556 Citations
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette Ma, Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui, Kwok Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. Riess, Mark Agulnik, Alex Y. Chang, Akhil Chopra, Julie A. Kish, Christine H. Chung, Douglas R. Adkins, Kevin J. Cullen, Barbara J. Gitlitz, Dean Lim, Ka‐Fai To, K.C. Allen Chan, Yuk Ming Dennis Lo, Ann D. King, Charles Erlichman, Jun Yin, Brian A. Costello, Anthony T.�C. Chan
Journal of Clinical Oncology. 2018473 CitationsOPEN ACCESS
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
Lucia Nogová, Lecia V. Sequist, José Manuel Pérez García, Fabrice André, Jean‐Pierre Delord, Manuel Hidalgo, Jan H.M. Schellens, Philippe A. Cassier, D. Ross Camidge, Martin Schüler, Ulka N. Vaishampayan, Howard A. Burris, Guangming Tian, Mario Campone, Zev A. Wainberg, Wan‐Teck Lim, Patricia LoRusso, Geoffrey I. Shapiro, Katie Parker, Xueying Chen, Somesh Choudhury, François Ringeisen, Diana Graus-Porta, Dale Porter, Randi Isaacs, Reinhard Buettner, Jürgen Wolf
Journal of Clinical Oncology. 2017438 CitationsOPEN ACCESS
Related on ScholarIQ
National Cancer Centre Singapore
Institution
Isolation and retrieval of circulating tumor cells using centrifugal forces
Paper
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
Paper
Genomic landscape of lung adenocarcinoma in East Asians
Paper
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Paper
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
Paper